BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

STATE STREET CORP's Holding History (CIK: 0000093751)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 15,675,000 Value ($000) $17,743 Avg Close — Range —
Q3 2025
Shares 14,825,000 Value ($000) $14,660 Avg Close — Range —
Q2 2025
Shares 14,325,000 Value ($000) $13,560 Avg Close — Range —
Q1 2025
Shares 13,950,000 Value ($000) $12,573 Avg Close — Range —
Q4 2024
Shares 15,150,000 Value ($000) $13,088 Avg Close — Range —
Q3 2024
Shares 14,650,000 Value ($000) $12,291 Avg Close — Range —
Q2 2024
Shares 14,350,000 Value ($000) $11,691 Avg Close — Range —
Q1 2024
Shares 16,450,000 Value ($000) $13,580 Avg Close — Range —
Q4 2023
Shares 17,450,000 Value ($000) $14,933 Avg Close — Range —
Q3 2023
Shares 19,100,000 Value ($000) $14,534 Avg Close — Range —
Q2 2023
Shares 17,100,000 Value ($000) $10,682 Avg Close — Range —
Q1 2023
Shares 15,100,000 Value ($000) $9,684 Avg Close — Range —
Q4 2022
Shares 17,100,000 Value ($000) $6,681 Avg Close — Range —
Q3 2022
Shares 17,100,000 Value ($000) $7,549 Avg Close — Range —
Q2 2022
Shares 16,150,000 Value ($000) $7,135 Avg Close — Range —
Q1 2022
Shares 17,150,000 Value ($000) $8,340 Avg Close — Range —